---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-037346"
form_type: "8-K"
ticker: "DCGO"
cik: "0001822359"
company_name: "DocGo Inc."
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T14:07:45.735762+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DocGo Q1 revenue $113M, net loss $3.9M; reaffirms FY2023 guidance

## Summary
- Q1 revenue $113.0M, down 4.2% YoY; ex-COVID testing, revenue up 40.2%.
- Net loss of $3.9M vs. net income of $9.4M in Q1 2022; Adj. EBITDA $5.6M.
- Gross margin 28.1% vs 33.9% YoY; cites startup costs from new project, expects recovery.
- Backlog rose to $205M from $180M; active RFPs doubled to ~$1.5B lifetime value.
- Reiterates FY2023 revenue guidance $500-$510M and Adj. EBITDA $45-$50M.

## SEC filing metadata
- accession: 0001213900-23-037346
- form_type: 8-K
- ticker: DCGO
- cik: 0001822359
- company_name: DocGo Inc.
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822359/000121390023037346/0001213900-23-037346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822359/000121390023037346/ea178143-8k_docgo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-037346
- JSON: https://secwatch.observer/filing/0001213900-23-037346.json
- Plain text: https://secwatch.observer/filing/0001213900-23-037346.txt

## Key facts
- Earnings Releases
  DocGo Inc. reported quarter ended March 31, 2023 results: revenue $113.0 million, net income Net loss was $3.9 million. Guidance reaffirmed.
  - Period: quarter ended March 31, 2023
  - Revenue: $113.0 million
  - Net income: Net loss was $3.9 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: today announced financial and operating results for the quarter ended March 31, 2023. Q1 2023 Financial Highlights ● Total revenue, net for the first quarter of 2023 was $113.0 million, compared to $117.9 million in the first quarter of 2022, a decrease of 4.2%. Excluding mass COVID testing revenue from both periods, revenue increased 40.2% from year ago
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822359/000121390023037346/0001213900-23-037346-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.